Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer

Cancer Immunology, Immunotherapy

Volumn 61, Issue 9, 2012, Pages 1591-1598

  Mechtcheriakova, Diana ^a   Svoboda, Martin ^a   Meshcheryakova, Anastasia ^a   Jensen Jarolim, Erika ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Activation induced cytidine deaminase; AllergoOncology symposium in writing; Cancer; Gene network; Inflammation; Multigene signature approach

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CANCER GENETICS; CANCER GROWTH; CARCINOGENESIS; CELL ACTIVATION; CHROMOSOME TRANSLOCATION; CHRONIC INFLAMMATION; COLORECTAL CANCER; CONFERENCE PAPER; DNA DAMAGE; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME REGULATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENOMIC INSTABILITY; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

ADAPTIVE IMMUNITY; ANIMALS; CYTIDINE DEAMINASE; ENZYME ACTIVATION; HUMANS; INFLAMMATION; NEOPLASMS;

EID: 84866557380     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1255-z     Document Type: Conference Paper

References (66)

1. MacLennan IC, Gray D (1986) Antigen-driven selection of virgin and memory B cells. Immunol Rev 91:61-85 (Pubitemid 16070599)
2. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-563
3. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, Honjo T (1999) Specific expression of activationinduced cytidine deaminase (AID), a novel member of the RNAediting deaminase family in germinal center B cells. J Biol Chem 274:18470-18476
4. Okazaki IM, Kinoshita K, Muramatsu M, Yoshikawa K, Honjo T (2002) The AID enzyme induces class switch recombination in fibroblasts. Nature 416:340-345 (Pubitemid 34260251)
5. Yoshikawa K, Okazaki IM, Eto T, Kinoshita K, Muramatsu M, Nagaoka H, Honjo T (2002) AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296: 2033-2036 (Pubitemid 34627527)
6. Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, Goodman MF, Scharff MD (2008) The biochemistry of somatic hypermutation. Annu Rev Immunol 26:481-511 (Pubitemid 351600383)
7. Di Noia JM, Neuberger MS (2007) Molecular mechanisms of antibody somatic hypermutation. Annu Rev Biochem 76:1-22
8. Marafioti T, Jones M, Facchetti F, Diss TC, Du MQ, Isaacson PG, Pozzobon M, Pileri SA, Strickson AJ, Tan SY, Watkins F, Mason DY (2003) Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood 102:2868-2876 (Pubitemid 37248859)
9. Moldenhauer G, Popov SW, Wotschke B, Bruderlein S, Riedl P, Fissolo N, Schirmbeck R, Ritz O, Moller P, Leithauser F (2006) AID expression identifies interfollicular large B cells as putative precursors of mature B-cell malignancies. Blood 107:2470-2473 (Pubitemid 43345569)
10. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102:565-575
11. Meyers G, Ng YS, Bannock JM, Lavoie A, Walter JE, Notarangelo LD, Kilic SS, Aksu G, Debre M, Rieux-Laucat F, Conley ME, Cunningham-Rundles C, Durandy A, Meffre E (2011) Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc Natl Acad Sci USA 108: 11554-11559. doi:10.1073/pnas.1102600108
12. Chahwan R, Wontakal SN, Roa S (2010) Crosstalk between genetic and epigenetic information through cytosine deamination. Trends Genet 26:443-448. doi:10.1016/j.tig.2010.07.005
13. Hauser J, Sveshnikova N, Wallenius A, Baradaran S, Saarikettu J, Grundstrom T (2008) B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins. PNAS 105:1267-1272 (Pubitemid 351397042)
14. Zhou C, Saxon A, Zhang K (2003) Human activation-induced cytidine deaminase is induced by IL-4 and negatively regulated by CD45: implication of CD45 as a Janus kinase phosphatase in antibody diversification. J Immunol 170:1887-1893 (Pubitemid 36197406)
15. Xu Z, Pone EJ, Al-Qahtani A, Park SR, Zan H, Casali P (2007) Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit Rev Immunol 27:367-397
16. Park SR, Zan H, Pal Z, Zhang J, Al-Qahtani A, Pone EJ, Xu Z, Mai T, Casali P (2009) HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, classswitch DNA recombination and somatic hypermutation. Nat Immunol 10:540-550
17. de Yebenes V, Belver L, Pisano DG, Gonzalez S, Villasante A, Croce C, He L, Ramiro AR (2008) miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J Exp Med 205:2199-2206
18. Dorsett Y, McBride KM, Jankovic M, Gazumyan A, Thai T-H, Robbiani DF, Di Virgilio M, San-Martin BR, Heidkamp G, Schwickert TA, Eisenreich T, Rajewsky K, Nussenzweig MC (2008) MicroRNA-155 suppresses activation-induced cytidine deaminasemediated Myc-Igh translocation. Immunity 28:630-638
19. Teng G, Hakimpour P, Landgraf P, Rice A, Tuschl T, Casellas R, Papavasiliou FN (2008) MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28:621-629
20. Wu X, Darce JR, Chang SK, Nowakowski GS, Jelinek DF (2008) Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B-cells. Blood 112:4675-4682
21. Mechtcheriakova D, Sobanov Y, Holtappels G, Bajna E, Svoboda M, Jaritz M, Bachert C, Jensen-Jarolim E (2011) Activationinduced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component. PLoS ONE 6:e25611. doi:10.1371/ journal.pone.0025611
22. McBride KM, Gazumyan A, Woo EM, Barreto VM, Robbiani DF, Chait BT, Nussenzweig MC (2006) Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc Natl Acad Sci USA 103:8798-8803 (Pubitemid 43878099)
23. McBride KM, Gazumyan A, Woo EM, Schwickert TA, Chait BT, Nussenzweig MC (2008) Regulation of class switch recombination and somatic mutation by AID phosphorylation. J Exp Med 205:2585-2594
24. Demorest ZL, Li M, Harris RS (2011) Phosphorylation directly regulates the intrinsic DNA cytidine deaminase activity of activation-induced deaminase and APOBEC3G protein. J Biol Chem 286:26568-26575. doi:10.1074/jbc.M111.235721
25. Ito S, Nagaoka H, Shinkura R, Begum N, Muramatsu M, Nakata M, Honjo T (2004) Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc Natl Acad Sci USA 101:1975-1980 (Pubitemid 38229000)
26. McBride KM, Barreto V, Ramiro AR, Stavropoulos P, Nussenzweig MC (2004) Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J Exp Med 199:1235-1244 (Pubitemid 38620260)
27. Brar SS, Watson M, Diaz M (2004) Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J Biol Chem 279: 26395-26401 (Pubitemid 38798791)
28. Patenaude AM, Orthwein A, Hu Y, Campo VA, Kavli B, Buschiazzo A, Di Noia JM (2009) Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol 16:517-527
29. Aoufouchi S, Faili A, Zober C, D'Orlando O, Weller S, Weill JC, Reynaud CA (2008) Proteasomal degradation restricts the nuclear lifespan of AID. J Exp Med 205:1357-1368 (Pubitemid 351831492)
30. Perez-Duran P, de Yebenes VG, Ramiro AR (2007) Oncogenic events triggered by AID, the adverse effect of antibody diversification. Carcinogenesis 28:2427-2433 (Pubitemid 350238943)
31. Stavnezer J (2011) Complex regulation and function of activation-induced cytidine deaminase. Trends Immunol 32:194-201. doi:10.1016/j.it.2011.03.003
32. Takhar P, Smurthwaite L, Coker HA, Fear DJ, Banfield GK, Carr VA, Durham SR, Gould HJ (2005) Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol 174:5024-5032
33. Takhar P, Corrigan CJ, Smurthwaite L, O'Connor BJ, Durham SR, Lee TH, Gould HJ (2007) Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J Allergy Clin Immuno 119:213-218 (Pubitemid 46037820)
34. Vicario M, Blanchard C, Stringer KF, Collins MH, Mingler MK, Ahrens A, Putnam PE, Abonia JP, Santos J, Rothenberg ME (2010) Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 59:12-20. doi: 10.1136/gut.2009.178020
35. Aloisi F, Pujol-Borrell R (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6:205-217 (Pubitemid 43290990)
36. Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, Spencer J, Pitzalis C (2009) Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 6:56-75
37. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA Jr, Marks JR, Dressman HK, West M, Nevins JR (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353-357 (Pubitemid 43128862)
38. Bild AH, Parker JS, Gustafson AM, Acharya CR, Hoadley KA, Anders C, Marcom PK, Carey LA, Potti A, Nevins JR, Perou CM (2009) An integration of complementary strategies for geneexpression analysis to reveal novel therapeutic opportunities for breast cancer. Breast Cancer Res 11:R55
39. Sparano JA, Paik S (2008) Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol 26:721-728 (Pubitemid 351264384)
40. Wei G, Twomey D, Lamb J, Schlis K, Agarwal J, Stam RW, Opferman JT, Sallan SE, den Boer ML, Pieters R, Golub TR, Armstrong SA (2006) Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 10:331-342 (Pubitemid 44512194)
41. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, la-Favera R (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412:341-346 (Pubitemid 32691848)
42. Shen HM, Michael N, Kim N, Storb U (2000) The TATA binding protein, c-Myc and survivin genes are not somatically hypermutated, while Ig and BCL6 genes are hypermutated in human memory B cells. Int Immunol 12:1085-1093 (Pubitemid 30599359)
43. Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, Honjo T (2003) Constitutive expression of AID leads to tumorigenesis. J Exp Med 197:1173-1181 (Pubitemid 36570072)
44. Wang CL, Harper RA, Wabl M (2004) Genome-wide somatic hypermutation. Proc Natl Acad Sci USA 101:7352-7356 (Pubitemid 38638036)
45. Feldhahn N, Henke N, Melchior K, Duy C, Soh BN, Klein F, von Levetzow G, Giebel B, Li A, Hofmann WK, Jumaa H, Müschen M (2007) Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells. J Exp Med 204:1157-1166 (Pubitemid 46798158)
46. Mitelman F, Johansson B, Mertens F (2007) The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 7:233-245 (Pubitemid 46480968)
47. Marusawa H (2008) Aberrant AID expression and human cancer development. Int J Biochem Cell Biol 40:1399-1402
48. Kim CJ, Song JH, Cho YG, Cao Z, Kim SY, Nam SW, Lee JY, Park WS (2007) Activation-induced cytidine deaminase expression in gastric cancer. Tumour Biol 28:333-339 (Pubitemid 351567551)
49. Babbage G, Ottensmeier CH, Blaydes J, Stevenson FK, Sahota SS (2006) Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res 66:3996-4000
50. Chen Z, Gu J (2007) Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J 21:2931-2938 (Pubitemid 47372759)
51. Shinmura K, Igarashi H, Goto M, Tao H, Yamada H, Matsuura S, Tajima M, Matsuda T, Yamane A, Funai K, Tanahashi M, Niwa H, Ogawa H, Sugimura H (2011) Aberrant expression and mutation-inducing activity of AID in human lung cancer. Ann Surg Oncol 18:2084-2092. doi:10.1245/s10434-011-1568-8
52. Komori J, Marusawa H, Machimoto T, Endo Y, Kinoshita K, Kou T, Haga H, Ikai I, Uemoto S, Chiba T (2008) Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma. Hepatology 47:888-896 (Pubitemid 351449680)
53. Endo Y, Marusawa H, Kinoshita K, Morisawa T, Sakurai T, Okazaki IM, Watashi K, Shimotohno K, Honjo T, Chiba T (2007) Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling. Oncogene 26:5587-5595 (Pubitemid 47267836)
54. Endo Y, Marusawa H, Kou T, Nakase H, Fujii S, Fujimori T, Kinoshita K, Honjo T, Chiba T (2008) Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology 135(889-98):898. doi:10.1053/j.gastro.2008.06.091
55. Takai A, Marusawa H, Minaki Y, Watanabe T, Nakase H, Kinoshita K, Tsujimoto G, Chiba T (2011) Targeting activationinduced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation. Oncogene. doi:10.1038/ onc.2011.352
56. Endo Y, Marusawa H, Chiba T (2011) Involvement of activationinduced cytidine deaminase in the development of colitis-associated colorectal cancers. J Gastroenterol 46(Suppl 1):6-10. doi: 10.1007/s00535-010-0326-1
57. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W (2002) Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17:629-638 (Pubitemid 35351508)
58. Kou T, Marusawa H, Kinoshita K, Endo Y, Okazaki IM, Ueda Y, Kodama Y, Haga H, Ikai I, Chiba T (2007) Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int J Cancer 120:469-476 (Pubitemid 44969015)
59. Casola S, Otipoby KL, Alimzhanov M, Humme S, Uyttersprot N, Kutok JL, Carroll MC, Rajewsky K (2004) B cell receptor signal strength determines B cell fate. Nat Immunol 5:317-327 (Pubitemid 38332129)
60. Roughan JE, Thorley-Lawson DA (2009) The intersection of Epstein-Barr virus with the germinal center. J Virol 83:3968-3976
61. Morgan HD, Dean W, Coker HA, Reik W, Petersen-Mahrt SK (2004) Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. J Biol Chem 279: 52353-52360 (Pubitemid 39656611)
62. Pauklin S, Sernandez IV, Bachmann G, Ramiro AR, Petersen-Mahrt SK (2009) Estrogen directly activates AID transcription and function. J Exp Med 206:99-111
63. Jensen-Jarolim E, Untersmayr E (2008) Gender-medicine aspects in allergology. Allergy 63:610-615. doi:10.1111/j.1398-9995. 2008.01645.x (Pubitemid 351490402)
64. Liu JQ, Joshi PS, Wang C, El-Omrani HY, Xiao Y, Liu X, Hagan JP, Liu CG, Wu LC, Bai XF (2010) Targeting activation-induced cytidine deaminase overcomes tumor evasion of immunotherapy by CTLs. J Immunol 184:5435-5443. doi:10.4049/jimmunol. 0903322
65. Bhutani N, Brady JJ, Damian M, Sacco A, Corbel SY, Blau HM (2010) Reprogramming towards pluripotency requires AIDdependent DNA demethylation. Nature 463:1042-1047
66. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R, Dalla-Favera R (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412:341-346 (Pubitemid 32691848)